Literature DB >> 17667917

Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges.

Ting Lei1, Sandrine Jacob, Imen Ajil-Zaraa, Jean-Bernard Dubuisson, Olivier Irion, Marisa Jaconi, Anis Feki.   

Abstract

Human embryonic stem cells (hESC) not only hold great promise for the treatment of degenerative diseases but also provide a valuable tool for developmental studies. However, the clinical applications of hESC are at present limited by xeno-contamination during the in vitro derivation and propagation of these cells. In this review, we summarize the current methodologies for the derivation and the propagation of hESC in conditions that will eventually enable the generation of clinical-grade cells for future therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667917     DOI: 10.1038/cr.2007.61

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  22 in total

1.  Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment.

Authors:  Emma Stephenson; Laureen Jacquet; Cristian Miere; Victoria Wood; Neli Kadeva; Glenda Cornwell; Stefano Codognotto; Yaser Dajani; Peter Braude; Dusko Ilic
Journal:  Nat Protoc       Date:  2012-06-21       Impact factor: 13.491

2.  Derivation and maintenance of human embryonic stem cell line on human adult skin fibroblast feeder cells in serum replacement medium.

Authors:  R Tayfur Tecirlioglu; Linh Nguyen; Karen Koh; Alan O Trounson; Anna E Michalska
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416

Review 3.  Deconstructing human embryonic stem cell cultures: niche regulation of self-renewal and pluripotency.

Authors:  Morag H Stewart; Sean C Bendall; Mickie Bhatia
Journal:  J Mol Med (Berl)       Date:  2008-06-03       Impact factor: 4.599

Review 4.  Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.

Authors:  Chad Tang; Micha Drukker
Journal:  Semin Immunopathol       Date:  2011-04-11       Impact factor: 9.623

Review 5.  Developing defined culture systems for human pluripotent stem cells.

Authors:  Bahram Valamehr; Hideaki Tsutsui; Chih-Ming Ho; Hong Wu
Journal:  Regen Med       Date:  2011-09       Impact factor: 3.806

Review 6.  Substrates and supplements for hESCs: a critical review.

Authors:  Melisa Candela Crocco; Nilo Fratnz; Adriana Bos-Mikich
Journal:  J Assist Reprod Genet       Date:  2013-01-04       Impact factor: 3.412

7.  Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation.

Authors:  Budd A Tucker; Kristin R Anfinson; Robert F Mullins; Edwin M Stone; Michael J Young
Journal:  Stem Cells Transl Med       Date:  2012-12-27       Impact factor: 6.940

8.  Improved efficiency of definitive endoderm induction from human induced pluripotent stem cells in feeder and serum-free culture system.

Authors:  Hiromasa Ninomiya; Keiko Mizuno; Reiko Terada; Toshiyuki Miura; Kiyoshi Ohnuma; Shuji Takahashi; Makoto Asashima; Tatsuo Michiue
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-08-15       Impact factor: 2.416

9.  Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen.

Authors:  Meredith B Jones; Chia H Chu; James C Pendleton; Michael J Betenbaugh; Joseph Shiloach; Bolormaa Baljinnyam; Jeffrey S Rubin; Michael J Shamblott
Journal:  Stem Cells Dev       Date:  2010-10-12       Impact factor: 3.272

10.  Multiplexing bioluminescent and fluorescent reporters to monitor live cells.

Authors:  Michael Haugwitz; Omar Nourzaie; Tatiana Garachtchenko; Lanrong Hu; Suvarna Gandlur; Cathy Olsen; Andrew Farmer; Grigoriy Chaga; Hiroaki Sagawa
Journal:  Curr Chem Genomics       Date:  2008-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.